Managed Account Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$1.5M Sell
61,105
-16,795
-22% -$375K ﹤0.01% 1938
2015
Q1
$1.6M Buy
77,900
+483
+0.6% +$9.36K ﹤0.01% 1945
2014
Q4
$1.54M Sell
77,417
-19,453
-20% -$334K ﹤0.01% 1928
2014
Q3
$1.43M Sell
96,870
-14,717
-13% -$234K ﹤0.01% 1929
2014
Q2
$2.05M Buy
111,587
+8,748
+9% +$146K ﹤0.01% 1777
2014
Q1
$1.94M Buy
+102,839
New +$2.11M ﹤0.01% 1748

Other funds holding ATRC

Managed Account Advisors's ATRC Position: Q2 2015 in Review

Managed Account Advisors reduced its AtriCure (ATRC) stake by 22% in Q2 2015, selling an estimated $375K and leaving 61,105 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

Managed Account Advisors first reported a position in ATRC in Q1 2014 and has held it in 6 quarters since. The position peaked at $2.05M in Q2 2014. 111 funds tracked by Wall St. Rank hold ATRC as of Q2 2015.

  • Managed Account Advisors held 61,105 shares of AtriCure worth $1.5M as of Q2 2015.
  • Managed Account Advisors sold 16,795 AtriCure shares in Q2 2015, an estimated $375K.
  • AtriCure made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1938 holding.
  • Managed Account Advisors first reported a position in AtriCure in Q1 2014 and has held it in 6 quarters since.
  • Managed Account Advisors's AtriCure position peaked at $2.05M in Q2 2014.
  • 111 funds tracked by Wall St. Rank held AtriCure as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.